- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01952067
Comparison of Two Cementing Techniques of the Femoral Component in a Hip Prosthesis
Comparison of Two Cementing Techniques of the Femoral Component in a Hip Prosthesis. A Randomized Single-blind Trial
The primary aim of the study is to compare migration of the cemented Corail stem representing polished surfaced versions of the femoral stem. Two different methods will be used for reaming the femoral canal and cementing of the stem. Radiostereometric analysis (RSA) will be used in migration measurements.
Furthermore pain, postoperative outcome and patient satisfaction will be assessed.
Study Overview
Status
Conditions
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Kristiansund, Norway
- Kristiansund Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Patients requiring cemented primary total hip replacement.
- Patients with a diagnosis of osteoarthritis, avascular necrosis or post-traumatic arthritis
- Patients who understand the conditions of the study and are willing and able to comply with the post-operative scheduled clinical and radiographic evaluations and the prescribed rehabilitation
- Patient who signed the Ethics Committee approved specific Informed Consent Form prior to surgery
Exclusion Criteria:
- Patients who require revision of a previously implanted total hip replacement (THR)
- Patients who will receive a THR without cement
- Patients who have had a prior procedure of osteotomy on the femur
- Obese patients where obesity is severe enough to affect subject's ability to perform activities of daily living (body mass index, kg/m2: BMI >35)
- Patients with active or suspected infection
- Patients with malignancy
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: line-to-line reaming
Corail cemented femoral stem using line-to-line reaming and cementing technique, 28mm Alumine Biolox forte femoral head, Marathon cup
|
|
|
Active Comparator: standard over-reaming
Corail cemented femoral stem using standard over-reaming with 2 broach sizes, 28mm Alumine Biolox forte femoral head, Marathon cup
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Difference in subsidence of femoral stems of 200 microns
Time Frame: change from 6th day postoperative to 24 months
|
Radiostereometric analysis (RSA) of implant migration: difference in translation and rotation (x-, y-, and z- axis) of the femoral stem
|
change from 6th day postoperative to 24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Oxford Hip Score
Time Frame: change from 6th day postoperative to 24 months
|
12 questions. Every question is scored 4 to 0 according to the selected response. Thus it is a continuous score ranging from 48-0. Each of the 12 questions on the Oxford hip score is scored in the same way with the score decreasing as the reported symptoms increase (ie. become worse). All questions are laid out similarly with response categories denoting least (or no) symptoms being to the left of the page (scoring 4) and those representing greatest severity lying on the right hand side (scoring 0). |
change from 6th day postoperative to 24 months
|
|
EQ-5D-5L
Time Frame: change from 6th day postoperative to 24 months
|
5 questions.
Every question is scored 1 to 5 where 5 is worse outcome.
For example one profile could be' 12233' We then convert this specific health state to an index value specific for that country.
The index value calculator can be downloaded from the EuroQol Office.
5 questions.
Every question is scored 1 to 5 where 5 is worse outcome.
For example one profile could be' 12233' We then convert this specific health state to an index value specific for that country.
The index value calculator can be downloaded from the EuroQol Office.
|
change from 6th day postoperative to 24 months
|
|
Harris Hip Score (HHS)
Time Frame: change from 6th day postoperative to 24 months
|
Four subscales make up HHS. The first is pain, which measures pain severity (44 points); function, which is made up of daily activities and gait (47 points); the absence of deformity, which is a subscale that measures hip flexion, adduction, internal rotation, leg length discrepancy and range of motion measures.(4 points), and range of motion (5 points). The survey has 10 question items and scores range from 0-100 with higher scores representing less dysfunction and better outcomes. |
change from 6th day postoperative to 24 months
|
|
Visual Assessment Scale (VAS) for pain
Time Frame: change from 6th day postoperative to 24 months
|
A horizontal or vertical 10 cm line labelled at each end by descriptors such as 'no pain' and 'worse pain ever'.
The patient marks the line to indicate pain severity and it is simply quantified by measuring the distance in cm from 0 (no pain) to the patient's marked rating.
|
change from 6th day postoperative to 24 months
|
|
Merle D'Aubigne scale
Time Frame: change from 6th day postoperative to 24 months
|
The score includes the parameters pain, mobility, and ability to walk, with each rated from 0 points (worst condition) to 6 points (best condition).
Addition of the scores for pain and mobility results in an absolute estimation of hip function.
|
change from 6th day postoperative to 24 months
|
Collaborators and Investigators
Investigators
- Study Director: Otto Schnell Husby, md phd, Norwegian University of Science and Technology
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 4.2008.1996
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Osteoarthritis, Hip
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip Osteoarthritis | Hip ArthropathyPoland
-
University of MiamiNot yet recruiting
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
Poznan University of Medical SciencesRecruitingHip Pain Chronic | Hip OsteoarthritisPoland
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis | Arthropathy of HipPoland
-
Poznan University of Medical SciencesRecruiting
-
Tulip MedicineCompletedRehabilitation | Hip Osteoarthritis | Hip Arthroplasty Replacement | Hip Arthroplasty, TotalKazakhstan
-
Istituto Ortopedico RizzoliCompleted
-
Poznan University of Medical SciencesNot yet recruitingHip Osteoarthritis
-
Artvin Coruh UniversityCompletedHip OsteoarthritisTurkey (Türkiye)
Clinical Trials on line-to-line reaming and cementing technique
-
Brno University HospitalNot yet recruiting
-
University of MichiganCompleted
-
Joint AcademyLund University; The Swedish Osteoarthritis RegistryRecruitingOsteoarthritis | First-line Treatment | Health Services AccessibilitySweden
-
George Washington UniversityJohns Hopkins UniversityCompletedPatients With Peripheral Intravenous Access LinesUnited States
-
University of Maryland, College ParkEnrolling by invitationGender Identity | Sexual OrientationUnited States
-
University of VermontNot yet recruitingOlder Adults (60 - 85 Years Old)
-
Rajiv Gandhi Cancer Institute & Research Center...UnknownRobotic Surgical ProceduresIndia
-
Novartis PharmaceuticalsCompleted
-
Johns Hopkins UniversityCompletedSmoking Cessation | Hypertension
-
National Rehabilitation Center, Seoul, KoreaUnknown